Summary Eisai Co Ltd (Eisai) is a pharmaceutical company that undertakes the research, development, manufacture and marketing of pharmaceuticals, including over-the-counter (OTC) drugs, prescription medicines and generics.The company’s franchise areas in research include neurology and oncology.
Eisai’s major products include Pariet/AcipHex (proton pump inhibitor); Aricept, an anti-Alzheimer’s agent; Halaven, a novel anti-cancer agent; Fycompa, an anti-epileptic and peripheral neuropathy treatment, among others.Eisai has production plants in Japan, the UK, China and India and laboratories in Japan, the US and the UK; overseas sales offices in the US, Germany, France, China and South Korea.
Eisai is headquartered in Tokyo, Japan.
Eisai Co Ltd (4523) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
Abstract Natural Disaster & Emergency Relief Services Procurement in the US Suppliers in this market provide food, shelter, clothing, medical relief, temporary shelters and counseling to victims of domestic disasters. Buyers in this market include federal agencies, local government agencies and...
2022 Maintenance and Repair Services for Precision Electronic Medical Equipment Global Market Size & Growth Report covers market size, revenue, growth, and share across 4 global regions, 22 subregions, and 216 countries. Figures are from 2012 through 2021, with forecasts for 2022 and 2026. The historical data utilizes in-depth survey...
Italy Cranio Maxillofacial Fixation (CMF) Procedures Outlook to 2025 - Cranio Maxillofacial Fixation (CMF) Procedures Summary “Italy Cranio Maxillofacial Fixation (CMF) Procedures Outlook to 2025” is a comprehensive databook report, covering key procedures data on the Italy Cranio Maxillofacial...
Market Overview The market for medical electrodes is being driven by factors such as the increasing prevalence of cardiovascular and neurological diseases, increasing investment for technological advancements by biopharmaceutical companies and rising focus towards minimally invasive surgeries. The rising population...
Summary Cyberonics, Inc. (Cyberonics) is a medical technology company that designs, develops and markets medical devices for the treatment of epilepsy and depression. The company offers vagus nerve stimulation therapy system used for treating refractory epilepsy and treatment-resistant depression. Its VNS therapy system consists...
This BCC Research report explores current and future strategies of vendors in the PMEP market, which includes products for diagnosis, testing, therapy and for first aid and other applications. Includes forecast through 2020. Use this report to: Analyze the portable medical equipment products (PMEPs) market and...
Summary Aerocrine AB (Aerocrine), a subsidiary of Circassia Pharmaceuticals Plc, is a medical products company. It markets and sells medical devices and tests. The company offers its products for diagnosis, treatment and monitoring of patients suffering from inflammation of airways. The company offers nitric oxide (NO) monitoring...
Summary Second Sight Medical Products Inc (Second Sight) is a medical device company that develops, manufactures and markets implantable visual prosthetics for blind individuals.The company offers Argus II retinal prosthesis system, a device that restores some functional vision for people suffering from blindness. It...
406 pages •
By Global Industry Analysts
• Feb 2019
This report analyzes the worldwide markets for Incontinence and Ostomy Care Products in US$ Thousand by the following Product Segments: Incontinence Products (Disposable Adult Diapers, Disposable Adult Shields, Disposable Under Pads, Drainage Bags, Incontinence Clamps, Incontinence Cleaners, Deodorizers & Urinals), and Ostomy Products...
This report forecasts to 2022 Canadian disposable medical supplies demand in nominal US dollars at the wholesale level. Total demand is segmented by product in terms of: surgical instruments and supplies; diagnostic and laboratory disposables; infusion and hypodermic devices; bandages and wound dressings; nonwoven medical...
Medical Supply
Medical Device
Surgical Equipment
Wholesaling
Traditional Wound Dressing
Medical Equipment
Sterilization Equipment
First-Aid Kit
Nonwoven Fabric
Medical Gloves
Respiratory Device
United States
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.